STRATA Skin Sciences (SSKN) Cash from Investing Activities (2010 - 2025)

STRATA Skin Sciences has disclosed Cash from Investing Activities across 16 years of filings, most recently posting -$312000.0 for Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at -$312000.0, up 38.1% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.5 million (up 10.27% YoY), and the FY2025 annual result was -$1.5 million, up 10.27% from the prior year.
• Cash from Investing Activities came in at -$312000.0 for Q4 2025 at STRATA Skin Sciences, up from -$1.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $194000.0 in Q3 2023 to a low of -$4.5 million in Q3 2021.
• The 5-year median for Cash from Investing Activities is -$733000.0 (2021), against an average of -$980800.0.
• Across the five-year window, Cash from Investing Activities jumped 136.81% in 2023 and sank 1541.94% in 2025, its largest moves.
• STRATA Skin Sciences' Cash from Investing Activities stood at -$1.1 million in 2021, then tumbled by 50.35% to -$1.7 million in 2022, then declined by 1.12% to -$1.7 million in 2023, then soared by 70.66% to -$504000.0 in 2024, then jumped by 38.1% to -$312000.0 in 2025.
• The last three Cash from Investing Activities figures came in at -$312000.0 (Q4 2025), -$1.0 million (Q3 2025), and $61000.0 (Q2 2025), per Business Quant data.